₨ 85,000
Adcetris (brentuximab vedotin) 50 mg is a prescription anti-cancer medication used to treat certain types of lymphomas. It is an antibody-drug conjugate that targets the CD30 protein found on cancer cells, delivering a substance that helps destroy them.
Key Information
- Active Ingredient: Brentuximab vedotin.
- Uses: It is used in the treatment of specific cases of:
- Classical Hodgkin lymphoma (cHL).
- Systemic anaplastic large-cell lymphoma (sALCL).
- Primary cutaneous anaplastic large-cell lymphoma (pcALCL) or CD30-expressing mycosis fungoides (MF).
- Large B-cell lymphoma (LBCL).
The specific use depends on the stage of the cancer and prior treatments.- Administration: It is administered by a healthcare professional as an intravenous (IV) infusion, typically every two or three weeks.
- Common Side Effects: Common side effects can include nerve problems (numbness, tingling, pain in hands or feet), fatigue, nausea, diarrhea, fever, and hair loss.
- Serious Warnings: Serious side effects, including a potentially fatal brain infection called Progressive Multifocal Leukoencephalopathy (PML), severe skin reactions, lung problems, and liver problems, can occur. Patients should be closely monitored by their doctor.
This medication requires a prescription and must be used under medical supervision.Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice. Always consult with a qualified healthcare provider for any questions regarding a medical condition or treatment.
₨ 10,000
